Evidence map›Paper›PMID 42792941›Full record

ArticleGenes2026

The Inhibition of Histone Lysine Demethylases Affects Head and Neck Cancer Cell Growth and Response to Cisplatin.

Dawid Dorna, Robert Kleszcz, Violetta Krajka-Kuźniak, Jarosław Paluszczak

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dawid DornaPoznan University of Medical Sciences, Doctoral School, 60-812 Poznań, Poland.ORCID 0000-0002-5972-5327
Robert KleszczPoznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, 60-806 Poznań, Poland.ORCID 0000-0002-6607-7436
Violetta Krajka-KuźniakPoznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, 60-806 Poznań, Poland.ORCID 0000-0001-7275-0298
Jarosław PaluszczakPoznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, 60-806 Poznań, Poland.ORCID 0000-0002-6187-7549

Funding

National Science Centre 2022/45/N/NZ7/01780
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CisplatinHead and Neck NeoplasmsHistone DemethylasesSquamous Cell Carcinoma of Head and NeckAminopyridinesAntineoplastic AgentsBenzazepinesCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansHydrazonesJumonji Domain-Containing Histone DemethylasesPyrimidinesQuinolonesRetinoblastoma-Binding Protein 2AminopyridinesAntineoplastic AgentsBenzazepinesCisplatinGSK-J4Histone DemethylasesHydrazonesJIB-04Jumonji Domain-Containing Histone DemethylasesKDM5A protein, humanKDM6A protein, humanPyrimidinesQuinolonesRetinoblastoma-Binding Protein 2cisplatinGSK-J4head and neck cancerhistone lysine demethylaseJIB-04KDM4KDM5KDM6ML324

Identifiers

PMID42792941
PMCPMC13606303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.